BridgeMD
New treatment option for Lung Cancer (Diagnosis)
Official title Effect of Apneic Oxygenation of the Non-ventilated Lung During Lung Cancer Surgery.
ClinicalTrials.gov ID: NCT07393490
What this study is testing
- What it's testing
- This study investigates the effect of apneic oxygenation of the non-ventilated lung on local and systemic inflammatory response during lung cancer surgery. Patients undergoing surgical resection of lung cancer often require one-lung ventilation during anaesthesia.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults aged 18 years or older
- Patients scheduled to undergo surgical resection of a single lung segment for lung cancer
- Written informed consent provided
You likely can't join if
- Age younger than 18 years
- Chronic corticosteroid therapy and/or other immunomodulatory treatments
- Severe pulmonary diseases, including: Chronic obstructive pulmonary disease classified as GOLD stage 3-4 (Global Initiative for Chronic Obstructive...
- Surgical procedure expected to last less than 2 hours
- Intraoperative hemodynamic instability, defined as: Mean arterial pressure \ 0.2 µg/kg/min)
- New-onset intraoperative cardiac arrhythmias
See the full eligibility criteria
- Adults aged 18 years or older
- Patients scheduled to undergo surgical resection of a single lung segment for lung cancer
- Written informed consent provided
- Age younger than 18 years
- Chronic corticosteroid therapy and/or other immunomodulatory treatments
- Severe pulmonary diseases, including: Chronic obstructive pulmonary disease classified as GOLD stage 3-4 (Global Initiative for Chronic Obstructive Lung Disease). Severe asthma according to GINA classification (Global...
- Surgical procedure expected to last less than 2 hours
- Intraoperative hemodynamic instability, defined as: Mean arterial pressure \ 0.2 µg/kg/min)
- New-onset intraoperative cardiac arrhythmias
- Significant intraoperative blood loss, defined as the need for transfusion of more than two units of packed red blood cells
- Intraoperative ventilatory instability, defined as: Severe hypoxemia (PaO₂ \ 70 mmHg with pH \< 7.2), inability to achieve adequate ventilation.
The study team makes the final eligibility decision.
Where it's taking place
- Osijek, Croatia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Osijek, Croatia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.